Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Notes Payables (2019 - 2020)

Arcadia Biosciences (RKDA) has disclosed Notes Payables for 4 consecutive years, with $161000.0 as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Notes Payables changed N/A year-over-year to $161000.0, compared with a TTM value of $161000.0 through Mar 2020, changed N/A, and an annual FY2019 reading of $24000.0, changed N/A over the prior year.
  • Notes Payables was $161000.0 for Q1 2020 at Arcadia Biosciences, up from $24000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $161000.0 in Q1 2020 and bottomed at $24000.0 in Q4 2019.